國家衛生研究院 NHRI:Item 3990099045/8524
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 916547      Online Users : 1466
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8524


    Title: Amacr gene amplification and protein overexpression in primary imatinib-naive gastrointestinal intestinal stromal tumors
    Authors: Li, CF;Huang, HY
    Contributors: National Institute of Cancer Research
    Abstract: Background: An integrative molecular and functional approach was aimed to identify amplified oncogenes on 5p and to validate the relevance of AMACR amplification and overexpression in gastrointestinal stromal tumors (GIST). Methods: GIST samples and cell lines were analyzed for DNA imbalances by array-based genomic profiling and quantified for AMACR mRNA expression. AMACR-specific FISH and immunohistochemistry were both informative in 350 independent primary GISTs, including 213 with confirmed KIT and PDGFRA genotypes. GIST cells were stably silenced against AMACR to assess its oncogenic functions. Results: 5p gains were differentially overrepresented in high-risk GISTs with 3 major amplicons, including one encompassing the mRNA-upregulated AMACR gene. Despite no amplification in 52% of AMACR-overexpressing GISTs, amplification (20%) and overexpression (38%) were strongly related to each other (p < 0.001). Apart from the associations with unfavorable genotypes, amplification and overexpression were strongly related to epithelioid histology, larger size, increased mitoses, and higher risk levels (all p = <0.003) and independently predictive of decreased disease-free survival (overexpression, p < 0.001; amplification, p = 0.020). Concomitant with downregulated cyclin D1, cyclin E, and CDK4, AMACR knockdown suppressed cell proliferation and induced G1-phase arrest but did not affect apoptosis in GIST cells. Conclusion: AMACR amplification is a mechanism driving increased mRNA and protein expression to confer aggressiveness on GISTs through heightened cell proliferation.
    Date: 2014-10
    Relation: Annals of Oncology. 2014 Oct;25:Article number P1-2-1.
    Link to: http://dx.doi.org/10.1093/annonc/mdu436.2
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0923-7534&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000347163700207
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    ISI000347163700207.pdf28KbAdobe PDF407View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback